These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2627551)

  • 41. Pasteurisation induced changes in an antithrombin III concentrate.
    Winkelman L; Haddon ME
    Thromb Res; 1986 Jul; 43(2):219-27. PubMed ID: 3738862
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigenic similarities between human plasma inhibitor of thrombin (At-III) and its analogues from other mammals.
    Detruit H; Blass J; Weiss M
    Biomedicine; 1979 Oct; 31(6):176-8. PubMed ID: 93495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Control of the cultivation process of antithrombin III and its characterization by capillary electrophoresis.
    Reif OW; Freitag R
    J Chromatogr A; 1994 Oct; 680(2):383-94. PubMed ID: 7981822
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigation on interaction of fractionated 3H-heparin with plasma proteins by gel filtration chromatography.
    Watanabe J; Nakagaki H; Yuasa H; Ozeki S
    J Pharmacobiodyn; 1989 Jul; 12(7):416-22. PubMed ID: 2480440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hamster antithrombin III: purification, characterization and acute phase response.
    Mak P; Enghild JJ; Dubin A
    Comp Biochem Physiol B Biochem Mol Biol; 1996 Sep; 115(1):135-41. PubMed ID: 8896339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Net biosynthesis of antithrombin III by the isolated rat liver perfused for 12--24 hours. Compared with rat fibrinogen and alpha-2 (acute-phase) globulin, antithrombin III is not an acute phase protein.
    Owens MR; Miller LL
    Biochim Biophys Acta; 1980 Jan; 627(1):30-9. PubMed ID: 6153276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the behaviour in vivo of two molecular forms of antithrombin III.
    Carlson TH; Atencio AC; Simon TL
    Biochem J; 1985 Feb; 225(3):557-64. PubMed ID: 3977846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antithrombin-heparin cofactor.
    Damus PS; Rosenberg RD
    Methods Enzymol; 1976; 45():653-69. PubMed ID: 64915
    [No Abstract]   [Full Text] [Related]  

  • 49. Separation of antithrombin III variants by micellar electrokinetic chromatography.
    Dönges R; Römisch J; Stauss H; Brazel D
    J Chromatogr A; 2001 Jul; 924(1-2):307-13. PubMed ID: 11521878
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective distribution of the heparin in mammals: conspicuous presence of heparin in lymphoid tissues.
    Nader HB; Takahashi HK; Straus AH; Dietrich CP
    Biochim Biophys Acta; 1980 Jan; 627(1):40-8. PubMed ID: 7353051
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of ultrasound on structure and functional properties of antithrombin III and proteins of PPSB complex.
    Shkumatov VM; Adzerikho IE; Lesnikovich JA; Cherniavsky EA
    Biochemistry (Mosc); 2004 Feb; 69(2):195-200. PubMed ID: 15000687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phosphotungstate as a useful eluent for antithrombin III purification by heparin-agarose affinity chromatography.
    Tajima Y; Shizuka R; Oshitani S; Amagai H
    Thromb Res; 1990 Mar; 57(5):697-704. PubMed ID: 2339364
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immobilization of heparin with trichloro-s-triazine: purification of mouse antithrombin.
    Finlay TH; Troll V; Hodgins LT
    Anal Biochem; 1980 Nov; 108(2):354-9. PubMed ID: 7457881
    [No Abstract]   [Full Text] [Related]  

  • 54. [Purification and physicochemical properties of antithrombin. (heparin cofacter) (author's transl)].
    Igarashi M; Asada T
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):202-6. PubMed ID: 70145
    [No Abstract]   [Full Text] [Related]  

  • 55. Studies on the relation between plasma antithrombin and heparin-cofactor.
    Monkhouse FC; Milojevic S
    Can J Physiol Pharmacol; 1968 May; 46(3):347-50. PubMed ID: 5698906
    [No Abstract]   [Full Text] [Related]  

  • 56. A novel matrix for high performance affinity chromatography and its application in the purification of antithrombin III.
    Zhao R; Luo J; Shangguan D; Liu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 816(1-2):175-81. PubMed ID: 15664348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of two distinct heparin cofactors in human plasma. Separation and partial purification.
    Briginshaw GF; Shanberge JN
    Arch Biochem Biophys; 1974 Apr; 161(2):683-90. PubMed ID: 4839055
    [No Abstract]   [Full Text] [Related]  

  • 58. Purification of canine antithrombin III-heparin cofactor using affinity chromatography.
    Damus PS; Wallace GA
    Biochem Biophys Res Commun; 1974 Dec; 61(4):1147-53. PubMed ID: 4141897
    [No Abstract]   [Full Text] [Related]  

  • 59. Microheterogeneity of plasma glycoproteins heparin cofactor II and antithrombin III and their carbohydrate analysis.
    Kim YS; Lee KB; Linhardt RJ
    Thromb Res; 1988 Jul; 51(1):97-104. PubMed ID: 3413738
    [No Abstract]   [Full Text] [Related]  

  • 60. Preparation of highly stable antithrombin-sepharose and utilization for the fractionation of heparin.
    Pixley R; Danishefsky I
    Thromb Res; 1982 Apr; 26(2):129-33. PubMed ID: 7112509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.